Amid US Blood Shortage, New Pressure to Ease Donor Rules for Gay Men
A three-month sexual abstinence rule for blood donations from sexually active gay and bisexual men should be dropped by the U.S. Food and Drug Administration.
HIV/AIDS
Outcomes of a Multicomponent Diagnostic Strategy for Tuberculosis Infection
Researchers conducted a study that compared a multicomponent diagnostic strategy with routine care for the diagnosis and treatment of tuberculosis infection.
HIV PrEP and Treatment Not Reaching Black and Hispanic/Latino Gay and Bisexual Men
The first injectable PrEP option for HIV may help reduce inequities among Black and Hispanic/Latino gay and bisexual men.
Zoledronate and Denosumab in Men With HIV on Antiretroviral Therapy
Antiretroviral therapy taken by people living with HIV decreases bone mineral density and increases fracture risk. Researchers investigated whether osteoporosis drugs denosumab and zolendronate could help men living with both osteoporosis and HIV.
Cash Transfers, Incentives for School Attendance May Decrease Incident HIV Risk in Women, Girls
Researchers conducted a study to determine whether government cash programs and programs that incentivize school attendance decrease the incidence of HIV infection among young women and adolescent girls.
Outcomes of Dolutegravir Treatment in Patients With HIV Infection Who Failed Antiretroviral Therapy
Researchers conducted a study to determine effect of a dolutegravir-based treatment regimen in patients with HIV infection.
Effect of Buprenorphine on Viral Suppression in Patients With HIV Infection
Researchers conducted a study among patients with HIV infection to assess the effect of buprenorphine on HIV viral loads.
FDA Approves Apretude, a Long-Acting Injectable for HIV PrEP
The application is supported by data from the phase 2b/3 HPTN 083 and HPTN 084 trials, which evaluated the efficacy and safety of Apretude for HIV PrEP.
Pediatricians Can Play Key Role in HIV Testing, Prophylaxis
In a clinical report, recommendations are presented for addressing HIV testing and preexposure and postexposure HIV prophylaxis in adolescents and young adults.
Number of Older People With HIV on ART Projected to Increase
If expected patterns in HIV diagnosis and survival continue, an estimated 23% of ART users in the year 2030 will be 65 years of age or older.
- Loading...
Loading...
Next post in HIV/AIDS
Loading... 
Loading...